Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Direct Meds

CoreAge Rx
Graded #1

Higher grade

vs+14.2
Direct Meds
Graded #35

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 77.6/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +7
92
85
Dose & formulationEven
88
88
Clinical oversightCoreAge Rx +38
93
55
Labs & monitoringCoreAge Rx +12
90
78
FulfillmentCoreAge Rx +15
95
80
Contract termsCoreAge Rx +16
96
80
CoreAge Rx · left barDirect Meds · right bar

The numbers

MetricCoreAge RxDirect Meds
WeighScore91.8/10077.6/100
GradeA−C+
Scorecard rank#1#35
Semaglutide$99/mo$249/mo sublingual · $297/mo injectable
Tirzepatide$149/mo$299/mo sublingual · $399/mo injectable
CoverageAll 50 statesNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
Direct Meds

Graded #35 · C+

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Strengths

  • Rare oral/sublingual option in addition to injectable
  • All-inclusive pricing with no separate membership fee
  • Both molecules — semaglutide and tirzepatide
  • Intro promotional pricing near $147

Where it loses points

  • Compounded only — not FDA-approved
  • Pricing is company-stated, not independently live-verified
  • Newer and somewhat ambiguous (operates across multiple domains)
  • States served are not disclosed

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard